Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

Circulation

Volumn 103, Issue 3, 2001, Pages 363-368

  Bhatt, Deepak L ^a   Chew, Derek P ^a   Hirsch, Alan T ^b   Ringleb, Peter A ^c   Hacke, Werner ^c   Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aspirin; Bypass; Grafting; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ADULT; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DRUG CHOICE; DRUG EFFICACY; FEMALE; GRAFT OCCLUSION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0035936484     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.3.363     Document Type: Article

References (43)

1. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years
2. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
3. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: Results of a Veterans Administration Cooperative Study
4. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: Results of a Veterans Administration Cooperative Study
5. Collaborative overview of randomised trials of antiplatelet therapy, II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
6. Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease
7. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries
8. Development of aspirin resistance in persons with previous ischemic stroke
9. The prevalence of aspirin resistance in cardiac patients as measured by platelet aggregation and the PFA-100
10. A randomised, blinded, trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE)
11. Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin
12. Thrombosed, ruptured Atheromatous plaques in saphenous vein coronary artery bypass grafts: Ten years' experience
13. Late thrombosis of saphenous vein coronary bypass grafts related to risk factors
14. The effect of anti-thrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts
15. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: A comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants: The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands
16. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts
17. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: A prospective, randomized study
18. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
19. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
20. Long-term graft patency (3 years) after coronary artery surgery: Effects of aspirin: Results of a VA Cooperative Study
21. Multiple myocardial infarctions associated with atheromatous emboli after PTCA of saphenous vein grafts: A clinicopathologic correlation
22. Recognition of the importance of embolization in atherosclerotic vascular disease
23. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
24. Effects of clopidogrel on platelet activation and coagulation of non-anticoagulated rat blood under high shear stress
25. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin
26. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans
27. Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine
28. Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically
29. Effect of ticlopidine on saphenous vein bypass patency rates: A double-blind study
30. Prevention of aorta-coronary bypass graft occlusion: Beneficial effect of ticlopidine on early and late patency rates of venous coronary bypass grafts: A double-blind study
31. Adverse hematological effects of ticlopidine: Prevention, recognition and management
32. Rash in patients receiving ticlopidine after intracoronary stent placement
33. Thrombotic thrombocytopenic purpura after stenting and ticlopidine
34. Thrombotic thrombocytopenic purpura related to ticlopidine
35. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting: EPISTENT Investigators: Evaluation of Platelet IIb/IIIa Inhibitor for Stenting
36. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation
37. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates
38. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: The Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study
39. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The Multicenter Aspirin and Ticlopidine Trial After Intracoronary Stenting (MATTIS)
40. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
41. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anti: Coagulation Restenosis Study Investigators
42. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents